Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision

(Euronext Amsterdam:NL0000009538),(NYSE:PHG), November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1] CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands […]

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision

Philips launches Verida, world's first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision GlobeNewswire November 30, 2025 November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1] CE-marked, 510k pending Verida CT [2] integrates AI across

DXCM CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors – a Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM)

(NASDAQ:DXCM), RADNOR, Pa., Nov. 30, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DexCom, Inc. (“DexCom”) (NASDAQ: DXCM) on behalf of those who purchased or otherwise acquired DexCom securities between January 8, 2024, and September 17, 2025,

DXCM CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors – a Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM)

DXCM CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors – a Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM) GlobeNewswire November 30, 2025 RADNOR, Pa., Nov. 30, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform

(Euronext Amsterdam:NL0000009538),(NYSE:PHG), November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform

Philips unveils BlueSeal Horizon, industry's first helium-free 3.0T MRI platform GlobeNewswire November 30, 2025 November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology,

Levi & Korsinsky Urges Marex Group plc (MRX) Shareholders to Act Before Lead Plaintiff Deadline December 8, 2025

NEW YORK, NY / ACCESS Newswire / November 30, 2025 / If you suffered a loss on your Marex Group plc (NASDAQ:MRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marex-group-plc-lawsuit-submission-form?prid=179354&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Levi & Korsinsky Urges DexCom, Inc. (DXCM) Shareholders to Act Before Lead Plaintiff Deadline December 26, 2025

NEW YORK, NY / ACCESS Newswire / November 30, 2025 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=179349&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Levi & Korsinsky Notifies aTyr Pharma, Inc. (ATYR) Investors – Lead Plaintiff Deadline on December 8, 2025

NEW YORK, NY / ACCESS Newswire / November 30, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=179365&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top